Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.
Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, Lauzon JL, Maltais F, O'Donnell DE, Goodridge D, Strange C, Cave AJ, Curren K, Muthuri S; Canadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working Group. Marciniuk DD, et al. Among authors: bourbeau j. Can Respir J. 2012 Mar-Apr;19(2):109-16. doi: 10.1155/2012/920918. Can Respir J. 2012. PMID: 22536580 Free PMC article.
Medical management of emphysema.
Maltais F, Bourbeau J. Maltais F, et al. Among authors: bourbeau j. Chest Surg Clin N Am. 1995 Nov;5(4):673-89. Chest Surg Clin N Am. 1995. PMID: 8574556 Review.
Self-management reduces both short- and long-term hospitalisation in COPD.
Gadoury MA, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupré A, Renzi P, Bégin R, Nault D, Bourbeau J; Chronic Obstructive Pulmonary Disease axis of the Respiratory Health Network, Fonds de la recherche en santé du Québec (FRSQ). Gadoury MA, et al. Among authors: bourbeau j. Eur Respir J. 2005 Nov;26(5):853-7. doi: 10.1183/09031936.05.00093204. Eur Respir J. 2005. PMID: 16264046 Free article. Clinical Trial.
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.
Aaron SD, Fergusson D, Marks GB, Suissa S, Vandemheen KL, Doucette S, Maltais F, Bourbeau JF, Goldstein RS, Balter M, O'Donnell D, Fitzgerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Aaron SD, et al. Among authors: bourbeau jf. Thorax. 2008 Feb;63(2):122-8. doi: 10.1136/thx.2007.082636. Epub 2007 Aug 16. Thorax. 2008. PMID: 17702790 Review.
Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.
Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Lomas DA, et al. Thorax. 2008 Dec;63(12):1058-63. doi: 10.1136/thx.2008.102574. Epub 2008 Aug 29. Thorax. 2008. PMID: 18757456
Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators. Lomas DA, et al. Eur Respir J. 2009 Jul;34(1):95-102. doi: 10.1183/09031936.00156508. Epub 2009 Jan 22. Eur Respir J. 2009. PMID: 19164344 Free article.
405 results